Detalhe da pesquisa
1.
Effect of baseline characteristics on the efficacy and safety of once-daily darunavir/ ritonavir in HIV-1-infected, treatment-naïve ARTEMIS patients at week 96.
HIV Clin Trials
; 12(6): 313-22, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-22189150
2.
Pharmacokinetics of darunavir/ritonavir and rifabutin coadministered in HIV-negative healthy volunteers.
Antimicrob Agents Chemother
; 54(10): 4440-5, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20660678
3.
Efficacy and safety of darunavir-ritonavir compared with that of lopinavir-ritonavir at 48 weeks in treatment-experienced, HIV-infected patients in TITAN: a randomised controlled phase III trial.
Lancet
; 370(9581): 49-58, 2007 Jul 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-17617272
4.
Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials.
Lancet
; 369(9568): 1169-78, 2007 Apr 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-17416261
5.
Darunavir/ritonavir pharmacokinetics following coadministration with clarithromycin in healthy volunteers.
J Clin Pharmacol
; 48(1): 60-5, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-18094220
6.
The effect of different meal types on the pharmacokinetics of darunavir (TMC114)/ritonavir in HIV-negative healthy volunteers.
J Clin Pharmacol
; 47(4): 479-84, 2007 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-17389557
7.
Pharmacokinetics of darunavir (TMC114) and atazanavir during coadministration in HIV-negative, healthy volunteers.
Drugs R D
; 8(4): 241-8, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17596110
8.
Pharmacokinetics of multiple-dose darunavir in combination with low-dose ritonavir in individuals with mild-to-moderate hepatic impairment.
Clin Pharmacokinet
; 49(5): 343-50, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20384396
9.
In vitro susceptibility and virological outcome to darunavir and lopinavir are independent of HIV type-1 subtype in treatment-naive patients.
Antivir Ther
; 15(8): 1161-9, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-21149923
10.
Pharmacokinetics, safety and efficacy of darunavir/ritonavir in treatment-experienced children and adolescents.
AIDS
; 23(15): 2005-13, 2009 Sep 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-19724191
11.
Characterization of virologic failure patients on darunavir/ritonavir in treatment-experienced patients.
AIDS
; 23(14): 1829-40, 2009 Sep 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-19474650
12.
Efficacy of once-daily darunavir/ritonavir 800/100 mg in HIV-infected, treatment-experienced patients with no baseline resistance-associated mutations to darunavir.
J Acquir Immune Defic Syndr
; 49(2): 179-82, 2008 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18769351
13.
Efficacy and safety of once-daily darunavir/ritonavir versus lopinavir/ritonavir in treatment-naive HIV-1-infected patients at week 48.
AIDS
; 22(12): 1389-97, 2008 Jul 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-18614861
14.